Shinji Fujimori
About Shinji Fujimori
Shinji Fujimori is a Senior Director of Process Development and Manufacturing at Erasca, Inc., with extensive experience in the pharmaceutical industry. He has held various roles at companies such as Myovant Sciences, Global Blood Therapeutics, and Gilead Sciences, and has a strong academic background in chemistry.
Work at Erasca
Shinji Fujimori serves as the Senior Director of Process Development and Manufacturing at Erasca, Inc. since 2021. His role involves overseeing the development and manufacturing processes within the organization, contributing to the company's focus on advancing cancer therapies. He operates from the San Francisco Bay Area, where Erasca is headquartered.
Previous Experience in the Biopharmaceutical Industry
Prior to his current position, Shinji Fujimori worked at Global Blood Therapeutics as the Director of Chemical Development from 2019 to 2021. He also held the position of Associate Director, API at Myovant Sciences from 2017 to 2019. His earlier experience includes roles as a Senior Scientist at Medivation in 2016 and as a Senior Research Scientist at Gilead Sciences from 2008 to 2016.
Educational Background in Chemistry
Shinji Fujimori earned a Bachelor of Arts in Chemistry from Lake Forest College, completing his studies from 1995 to 1999. He furthered his education by obtaining a PhD in Organic Chemistry from the University of Illinois at Urbana-Champaign, where he studied from 1999 to 2005. Additionally, he completed a postdoctoral research position in Organic Chemistry at Eidgenössische Technische Hochschule Zürich from 2005 to 2007.
Career Progression in Chemical Development
Shinji Fujimori's career in chemical development began at Merck as a Senior Chemist from 2007 to 2008. He then transitioned to Gilead Sciences, where he spent eight years as a Senior Research Scientist. After a brief stint at Pfizer in 2016, he continued to advance his career in the biopharmaceutical sector, culminating in his current role at Erasca.